Premium
STEVENS–JOHNSON SYNDROME AFTER SERIAL–C MEDICATION
Author(s) -
O'Callaghan John,
Jones Graham
Publication year - 1972
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1972.tb47013.x
Subject(s) - erythema multiforme , megestrol acetate , dermatology , medicine , erythema , pediatrics , cancer
The Stevens‐Johnson syndrome (erythema exudativum multiforme) has been described as an eruptive disorder of the skin and mucous membranes, with an acute systemic reaction. In the 50 years since Stevens and Johnson's initial reports in 1922, the syndrome has been recorded as occurring after medication with a large variety of drugs. A case is described of the Stevens‐Johnson syndrome occurring in a 15‐year‐old girl after medication with the anovulant Serial‐C, containing the œstrogens ethinyl œstradiol (0.1 mg) and the progesterone derivative, megestrol acetate (0.1 to 1.0 mg).